Detalhe da pesquisa
1.
Cytogenetic outcomes following a failed cell-free DNA screen: a population-based retrospective cohort study of 35,146 singleton pregnancies.
Am J Obstet Gynecol
; 229(2): 168.e1-168.e8, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36627072
2.
Performance of a universal prenatal screening program incorporating cell-free fetal DNA analysis in Ontario, Canada.
CMAJ
; 193(30): E1156-E1163, 2021 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34344770
3.
A 2-year review of publicly funded cell-free DNA screening in Ontario: utilization and adherence to funding criteria.
Prenat Diagn
; 40(2): 164-172, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31525278
4.
Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions in Average-Risk Pregnancies: A Cost-Effectiveness Analysis.
J Obstet Gynaecol Can
; 42(6): 740-749.e12, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32008974
5.
The Ontario Birth Study: A prospective pregnancy cohort study integrating perinatal research into clinical care.
Paediatr Perinat Epidemiol
; 32(3): 290-301, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29750375
6.
Highlights of the 26th ISPD annual conference, hosted in a vibrant Canadian city along with the Montreal grand prix 2022.
Prenat Diagn
; 43(4): 409-410, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36919754
7.
Informed Decision-Making in the Context of Prenatal Chromosomal Microarray.
J Genet Couns
; 27(5): 1130-1147, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29516345
8.
Enhanced First Trimester Screening for Trisomy 21 with Contingent Cell-Free Fetal DNA: A Comparative Performance and Cost Analysis.
J Obstet Gynaecol Can
; 39(9): 742-749, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28624447
9.
Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
J Obstet Gynaecol Can
; 38(8): 742-762.e3, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27638987
10.
Excluding pregnancy from COVID-19 trials: Protection from harm or the harm of protection?
CMAJ
; 192(23): E634, 2020 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32575055
11.
Antepartum Screening for Maternal Infection and Immune Status: Is it Time to Broaden Our Routine?
J Obstet Gynaecol Can
; 37(12): 1118-21, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26637086
12.
Ultrasonographic Fetal Nuchal Translucency Measurements and Cytogenetic Outcomes.
JAMA Netw Open
; 7(3): e243689, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38530313
13.
The impact of maternal weight discrepancies on prenatal screening results for Down syndrome.
Prenat Diagn
; 33(5): 471-6, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23512612
14.
Au-delà de l'aneuploïdie : pour une approche canadienne moderne en matière de dépistage prénatal.
J Obstet Gynaecol Can
; 40(3): 276-278, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29525042
15.
Beyond Fetal Aneuploidy: A Call For A Contemporary Canadian Approach To Prenatal Screening.
J Obstet Gynaecol Can
; 40(3): 273-275, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29525041
16.
First and second trimester maternal serum markers for prenatal aneuploidy screening: An update on the adjustment factors for race, smoking, and insulin dependent diabetes mellitus.
Clin Biochem
; 118: 110596, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37295638
17.
Combinations of maternal serum markers to predict preeclampsia, small for gestational age, and stillbirth: a systematic review.
J Obstet Gynaecol Can
; 34(2): 142-153, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22340063
18.
Opinion commune de la SOGC et du CCGM sur le dépistage génétique en contexte de procréation : Mise à jour à l'intention de l'ensemble des prestataires canadiens de soins de santé maternelle et de services en procréation, à l'ère des tests offerts directement aux consommateurs.
J Obstet Gynaecol Can
; 38(8): 763-787.e4, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27638988
19.
Fetal anatomic survey using three-dimensional ultrasound in conjunction with first-trimester nuchal translucency screening.
Prenat Diagn
; 30(3): 267-73, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20073060
20.
An assessment of women's knowledge of and views on the reporting of ultrasound soft markers during the routine anatomy ultrasound examination.
J Obstet Gynaecol Can
; 32(2): 120-125, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20181312